Impact of TSC2 loss on progression-free survival in uterine carcinosarcoma: A retrospective analysis

Objective: Uterine carcinosarcoma (UCS) is a rare and aggressive gynecological cancer with high recurrence rates and is associated with a poor prognosis. It is also characterized by a high frequency of copy number alterations (CNAs). This study aimed to determine which gene CNA contributes to progre...

Descripció completa

Dades bibliogràfiques

Autors principals:	Ryoko Ichikawa, Tamotsu Sudo, Kyohei Takada, Akiko Ohwaki, Mayuko Ito, Yusuke Shimizu, Mayu Takeda, Eiji Sugihara, Tetsuya Takimoto, Haruki Nishizawa
Format:	Artigo
Idioma:	Inglês
Publicat:	Fujita Medical Society 2025-11-01
Col·lecció:	Fujita Medical Journal
Matèries:	uterine carcinosarcoma tsc2 loss mtor inhibitor
Accés en línia:	https://www.jstage.jst.go.jp/article/fmj/11/4/11_2025-001/_pdf/-char/en
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!